Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses

Show full item record



Permalink

http://hdl.handle.net/10138/312891

Citation

Haveri , A , Ikonen , N , Kantele , A , Anttila , V-J , Ruotsalainen , E , Savolainen-Kopra , C & Julkunen , I 2019 , ' Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses ' , Vaccine , vol. 37 , no. 20 , pp. 2731-2740 . https://doi.org/10.1016/j.vaccine.2019.03.078

Title: Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses
Author: Haveri, Anu; Ikonen, Niina; Kantele, Anu; Anttila, Veli-Jukka; Ruotsalainen, Eeva; Savolainen-Kopra, Carita; Julkunen, Ilkka
Contributor organization: Department of Medicine
Department of Bacteriology and Immunology
Anu Kantele-Häkkinen Research Group
Infektiosairauksien yksikkö
HUS Inflammation Center
University of Helsinki
HUS Internal Medicine and Rehabilitation
Date: 2019-05-06
Language: eng
Number of pages: 10
Belongs to series: Vaccine
ISSN: 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2019.03.078
URI: http://hdl.handle.net/10138/312891
Abstract: Influenza A(H1N1)pdm09 viruses have been circulating throughout the world since the 2009 pandemic. A/California/07/2009 (H1N1) virus was included in seasonal influenza vaccines for seven years altogether, providing a great opportunity to analyse vaccine-induced immunity in relation to the postpandemic evolution of the A(H1N1)pdm09 virus. Serum antibodies against various epidemic strains of influenza A (H1N1)pdm09 viruses were measured among health care workers (HCWs) by haemagglutination inhibition and microneutralization tests before and after 2010 and 2012 seasonal influenza vaccinations. We detected high responses of vaccine-induced neutralizing antibodies to six distinct genetic groups. Our results indicate antigenic similarity between vaccine and circulating A(H1N1)pdm09 strains, and substantial vaccine-induced immunity against circulating epidemic viruses. (C) 2019 Published by Elsevier Ltd.
Subject: Antibodies
Microneutralization test
Humoral immunity
Influenza A
Pandemic
Vaccine
HEMAGGLUTINATION INHIBITION
H1N1 2009
ANTIGENIC STRUCTURE
PHASE-III
IMMUNOGENICITY
SAFETY
VACCINATION
CANDIDATE
CHILDREN
A(H3N2)
3111 Biomedicine
1183 Plant biology, microbiology, virology
3121 General medicine, internal medicine and other clinical medicine
Peer reviewed: Yes
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
Seasonal_influe ... a_A_H1N1_pdm09_viruses.pdf 1.776Mb PDF View/Open
1_s2.0_S0264410X1930427X_main.pdf 1.716Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record